Lethal osteogenesis imperfecta with amniotic band lesions: collagen studies

Area of Science:

• Biochemistry and Molecular Biology
• Genetics and Genetic Diseases
• Pediatric Pathology

Background:

• Osteogenesis imperfecta (OI) is a group of genetic disorders characterized by fragile bones.
• Type I collagen is the primary structural protein in bone, and mutations in its genes are implicated in OI.
• Accurate classification and genetic counseling in OI are crucial for patient management.

Observation:

• An infant with clinical features suggestive of type III OI presented with limb malformations and died shortly after birth.
• Histomorphometric analysis revealed significantly reduced trabecular bone volume due to impaired osteoblast matrix apposition.
• Collagen studies showed reduced solubility and the presence of shortened type I collagen molecules in bone and skin.

Findings:

• Shortened alpha 1 and alpha 2 chains of type I collagen, approximately 10 kDa lighter than normal, were identified.
• Pepsin digestion of demineralized bone matrix yielded shortened type I collagen molecules, indicating increased enzymatic susceptibility.
• Detailed analysis confirmed the shortened alpha 1 chain originated from the N-terminal end, extending into the triple helix, affecting approximately 120 residues.

Implications:

• This study demonstrates a specific structural abnormality in type I collagen, leading to increased proteolysis in osteogenesis imperfecta.
• The findings highlight the necessity of integrating biochemical data with clinical observations for accurate OI classification and genetic counseling.
• Understanding these molecular defects can lead to improved diagnostic approaches and potential therapeutic strategies for OI.